Call Options

24 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2023

Apr 14, 2023

SELL
$39.39 - $51.28 $1.16 Million - $1.51 Million
-29,400 Reduced 98.66%
400 $16,000
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $50,100 - $65,400
-1,200 Reduced 3.87%
29,800 $1.53 Million
Q3 2022

Oct 25, 2022

BUY
$43.76 - $53.42 $201,296 - $245,732
4,600 Added 17.42%
31,000 $61,000
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $2.11 Million - $2.5 Million
-45,400 Reduced 63.23%
26,400 $239,000
Q1 2022

May 11, 2022

SELL
$45.75 - $56.69 $695,400 - $861,688
-15,200 Reduced 17.47%
71,800 $678,000
Q4 2021

Feb 08, 2022

SELL
$41.32 - $61.25 $818,136 - $1.21 Million
-19,800 Reduced 18.54%
87,000 $1.24 Million
Q3 2021

Nov 02, 2021

SELL
$39.25 - $50.42 $1.55 Million - $1.99 Million
-39,400 Reduced 26.95%
106,800 $266,000
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $1.24 Million - $1.4 Million
34,500 Added 30.89%
146,200 $89,000
Q1 2021

May 14, 2021

BUY
$33.49 - $37.77 $991,304 - $1.12 Million
29,600 Added 36.05%
111,700 $54,000
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $1.02 Million - $1.29 Million
30,400 Added 58.8%
82,100 $17,000
Q3 2020

Nov 04, 2020

BUY
$31.75 - $37.25 $479,425 - $562,475
15,100 Added 41.26%
51,700 $28,000
Q2 2020

Jul 28, 2020

SELL
$30.12 - $36.54 $5.42 Million - $6.57 Million
-179,900 Reduced 83.09%
36,600 $9,000
Q1 2020

Apr 21, 2020

BUY
$27.03 - $38.62 $383,826 - $548,404
14,200 Added 7.02%
216,500 $56,000
Q4 2019

Feb 12, 2020

BUY
$32.92 - $37.36 $164,600 - $186,800
5,000 Added 2.53%
202,300 $40,000
Q3 2019

Nov 07, 2019

SELL
$32.49 - $42.13 $4.31 Million - $5.59 Million
-132,600 Reduced 40.19%
197,300 $18,000
Q2 2019

Aug 06, 2019

BUY
$36.98 - $41.52 $3.98 Million - $4.46 Million
107,500 Added 48.34%
329,900 $204,000
Q1 2019

May 06, 2019

BUY
$37.5 - $41.2 $3.05 Million - $3.35 Million
81,400 Added 57.73%
222,400 $38,000
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $6.78 Million - $7.73 Million
-176,200 Reduced 55.55%
141,000 $183,000
Q3 2018

Nov 14, 2018

BUY
$34.47 - $41.81 $3.14 Million - $3.81 Million
91,200 Added 40.35%
317,200 $878,000
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $916,843 - $977,447
-27,800 Reduced 10.95%
226,000 $126,000
Q1 2018

May 14, 2018

SELL
$31.91 - $37.02 $3.05 Million - $3.54 Million
-95,600 Reduced 27.36%
253,800 $164,000
Q4 2017

Feb 14, 2018

SELL
$33.26 - $35.29 $1.35 Million - $1.43 Million
-40,600 Reduced 10.41%
349,400 $209,000
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $2.32 Million - $2.55 Million
74,700 Added 23.69%
390,000 $310,000
Q2 2017

Aug 14, 2017

BUY
N/A
315,300
315,300 $63,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.